A detailed history of Core Cap Advisors, LLC transactions in Prenetics Global LTD stock. As of the latest transaction made, Core Cap Advisors, LLC holds 25 shares of PRE stock, worth $191. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Holding current value
$191
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$3.29 - $11.23 $82 - $280
25 New
25 $0

Others Institutions Holding PRE

# of Institutions
1
Shares Held
25
Call Options Held
0
Put Options Held
0

About Prenetics Global Ltd


  • Ticker PRE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 101,265,000
  • Market Cap $777M
  • Description
  • Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplif...
More about PRE
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.